These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10343445)

  • 21. Clinicians debate antiretroviral tactics and toxicities, resistance testing, and hepatitis virus coinfection. IAPAC sessions 2002 - May 16-17, 2002.
    Mascolini M
    IAPAC Mon; 2002 Jul; 8(7):190-201. PubMed ID: 12154789
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.
    Burnett RJ; François G; Kew MC; Leroux-Roels G; Meheus A; Hoosen AA; Mphahlele MJ
    Liver Int; 2005 Apr; 25(2):201-13. PubMed ID: 15780040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avoiding the challenges of emerging infectious disease and antibiotic resistance.
    Molinari JA
    J Mass Dent Soc; 2000; 49(3):8-9, 51. PubMed ID: 11323859
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intervention against malaria requires international solidarity. Institutions and drug industry should find new forms of collaboration].
    Björkman A
    Lakartidningen; 2004 Jan; 101(5):384-8. PubMed ID: 14986448
    [No Abstract]   [Full Text] [Related]  

  • 25. Rational use of antibiotics to treat respiratory tract infections.
    File TM; Hadley JA
    Am J Manag Care; 2002 Aug; 8(8):713-27. PubMed ID: 12212759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key developments in the battle against infection.
    Venkatesan P
    Practitioner; 1997 Dec; 241(1581):720-2. PubMed ID: 9926601
    [No Abstract]   [Full Text] [Related]  

  • 27. The priorities for antiviral drug resistance surveillance and research.
    Pillay D
    J Antimicrob Chemother; 2007 Aug; 60 Suppl 1():i57-8. PubMed ID: 17656384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overuse of antibiotics leads to "super bugs".
    Kennedy M
    WMJ; 2000 Aug; 99(5):22-3, 28. PubMed ID: 11043064
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.
    Benhamou Y; Bochet M; Thibault V; Di Martino V; Caumes E; Bricaire F; Opolon P; Katlama C; Poynard T
    Hepatology; 1999 Nov; 30(5):1302-6. PubMed ID: 10534354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral therapies.
    Hallenberger S
    J Clin Virol; 2004 Apr; 30 Suppl 1():S23-5. PubMed ID: 15062765
    [No Abstract]   [Full Text] [Related]  

  • 31. Prescribers urged to resist patients' pleas for antibiotics.
    Nurs Stand; 2013 Sep 18-24; 28(3):9. PubMed ID: 24044821
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-resistant viral hepatitis.
    Wright M; Main J; Thomas HC
    J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
    [No Abstract]   [Full Text] [Related]  

  • 33. The need for new antibiotics.
    Baiden F; Owusu-Agyei S; Webster J; Chandramohan D
    Lancet; 2010 Feb; 375(9715):637-8. PubMed ID: 20171396
    [No Abstract]   [Full Text] [Related]  

  • 34. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
    Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chapter 5.9: major public health problems - infectious disease.
    Carlson J
    Scand J Public Health Suppl; 2006 Jun; 67():132-8. PubMed ID: 16762906
    [No Abstract]   [Full Text] [Related]  

  • 36. Controlling antimicrobial resistance. An integrated action plan for Canadians.
    Health Canada and The Canadian Infectious Disease Society
    Can Commun Dis Rep; 1997 Nov; 23 Suppl 7():i-iv, 1-32, i-iv, 1-32. PubMed ID: 11195276
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
    Zoulim F
    Antivir Chem Chemother; 2001; 12 Suppl 1():131-42. PubMed ID: 11594680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infectious diseases: annual review of significant publications.
    Reimann HA
    Postgrad Med J; 1970 May; 46(535):283-99. PubMed ID: 4317639
    [No Abstract]   [Full Text] [Related]  

  • 39. [The selected contagions].
    Aavitsland P; Helland A
    Tidsskr Nor Laegeforen; 2008 Oct; 128(20):2304. PubMed ID: 19096483
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B, lamivudine, and HIV.
    Kuchimanchi U; Rooney G
    BMJ; 2001 Jul; 323(7303):51. PubMed ID: 11464832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.